Scholars call for greater transparency in how FDA uses subjective evidence in treatments for brain injuries.
Scholar examines the institutional review board process for resolving disputes in human subjects research.
Regulators and policymakers review old rules and propose new guidelines for rationing ventilators.
FDA clarifies its generic drug approval process in an effort to encourage market competition.
FDA clarifies enforcement priorities for medical device clinical decision support software.
FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.
FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.
Experts suggest changing Medicare’s payment structure to encourage physicians to pursue primary care specialties.
Scholar says that human milk should be regulated to ensure donor milk is safe, accessible, and affordable.
Scholar argues that the association between cosmetics and femininity has contributed to harmful under-regulation.
Scholar argues that FDA should use a narrowly tailored framework to regulate encapsulated placenta pills.
Scholars caution against using the Right to Try Act to skirt regulation for regenerative therapies.